3579 results for «301»

Filter By

3579 results

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

EuroPCR 2021 - Innovations in peripheral and structural interventions

18 May 2021 – From EuroPCR 2021

In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.

EuroPCR 2021 - Innovations in peripheral and structural interventions

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

20 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

The new Evolut PRO+ system: optimal procedural outcomes in all patients

20 May 2021 – From EuroPCR 2021

Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...

The new Evolut PRO+ system: optimal procedural outcomes in all patients

Improving personalised vascular care using novel technologies: how can I start?

19 May 2021 – From EuroPCR 2021

Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.

Improving personalised vascular care using novel technologies: how can I start?

Coronary access after TAVI, a growing need

20 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...

Coronary access after TAVI, a growing need

Sustained Limus release, redefining indications for drug-eluting balloons

20 May 2021 – From EuroPCR 2021

Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...

Sustained Limus release, redefining indications for drug-eluting balloons

Complications during complex PCI

14 Apr 2021 – From EuroPCR 2021

Don't miss this session if you want to be prepared if you discover what you can least expect during complex PCI, or in case of uncommon complication during a complex PCI procedure.

EuroPCR 2021 Complications during complex PCI

Complications during radial access

14 Apr 2021 – From EuroPCR 2021

Watch this session to find out more about a life-threatening complication of radial access, together with a rare complication highlighting the need to respect the radial artery.

EuroPCR 2021 Complications during radial access

Calcified arteries: rotablation, lithotripsy or both? - Part 3

28 Apr 2021 – From EuroPCR 2021

This session aims at helping you learn how to face a right coronary artery calcium storm with undilatable lesions, find out more about PCI of a heavily calcified aorto-ostial RCA lesion, and analyze how to react when facing a calcific tortuous RCA with lesion on bend.

EuroPCR 2021 Calcified arteries: rotablation, lithotripsy or both? - Part 3

Complications in complex rotational atherectomy

This session will help you get prepared if you have to become familiar with a novel way to release stuck rotational atherectomy burr, deal with severely calcified RCA including removal of a stuck Rotablator, or cope when Rotablator burr catheter entraps.

EuroPCR 2021 Complications in complex rotational atherectomy

TAVI in a patient with coronary artery disease - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.

This session was originally presented during EuroPCR 2021.

TAVI in a patient with coronary artery disease

How to prevent and manage coronary perforation?

19 May 2021 – From EuroPCR 2021

Watch this session if you want to learn about the different types of coronary perforation, to discuss how to predict which situations and coronary anatomies are particularly at risk of coronary perforation, and to share practical tips for rapid and effective management of coronary perforation.

This session...

How to prevent and manage coronary perforation?

Left Main and bifurcation PCI - Session with LIVE demonstration

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand how to adapt your treatment strategy to the underlying anatomy, to learn the steps of provisional left main PCI and to discuss the pitfalls of provisional left main PCI.

This session was originally presented during EuroPCR 2021.

Left Main and bifurcation PCI

EuroPCR 2021 Hotlines / Late-Breaking Trials in renal denervation: EFFECTIVENESS

25 May 2021 – From EuroPCR 2021

Find out more about the EFFECTIVENESS trial regarding renal denervation.

EuroPCR 2021 Hotlines / Late-Breaking Trials in renal denervation: EFFECTIVENESS

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?